News & Updates

Latest News & Updates

Apotex is proud to be delivering important savings to the Canadian Healthcare System, and to patients with Multiple Myeloma and Myelodysplastic Syndrome, with our MADE IN CANADA lenalidomide product.

The purpose of this study is to gain a better understanding of the febrile neutropenia treatment protocols used across Canada for adult patients receiving chemotherapy for solid organ cancers.

CAPhO members are invited to attend the Charting New Directions in the Treatment and Management of Chronic Lymphocytic Leukemia session hosted by AstraZeneca.

Presented by Esther Jadusingh Tuesday, October 12, 2021 at 10:00 PDT, 11:00 MDT, 11:00 CST, 13:00 EDT, 14:00 ADT, 14:30 NDT

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market

OFD 2021 takes place on Friday, October 22 and Saturday, October 23, 2021 as a two day CCCEP accredited online learning event. Register now!

Congratulations to all of the CAPhO members who received an Award in 2021

Maria Marchese

CAPhO member Maria Marchese received a 2020 research grant for her project, Perceptions and Experiences of Cancer Patients Accessing a Pharmacist-led Medical Cannabis Consultation Service in Toronto, Canada. Read more about the project in this latest post.

Read more about Philip Shaheen's memories as his time as CAPhO President.

It is amazing to think that CAPhO is already 25 years old!  It seems like just yesterday, this was a dream of Larry Broadfield's and now look at the thriving organization CAPhO has become!